AEON,AEON Biopharma, Inc. | Healthcare

Healthcare

AEON

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

AEON Biopharma, Inc.AEON

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

Market Cap

4.21M

Revenue (ttm)

n/a

Net Income (ttm)

42.01M

Shares Out

10.53M

EPS (ttm)

72.93

PE Ratio

0.01

Forward PE

n/a

Dividend

n/a

Ex-Dividend Date

n/a

Volume

89,698

Open

0.4099

Previous Close

0.4090

Day's Range

0.3770 - 0.4158

52-Week Range

0.3770 - 619.2000

Beta

0.35

Analysts

Strong Buy

Price Target

360.00 (+89,877.51%)

Earnings Date

May 13, 2025

Description >

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins.

It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine.

AEON Biopharma, Inc. is based in Irvine, California.

Latest News >

Taiwan chipmaker TSMC approves $3.8 billion Germany factory plan

Aug 8, 2023

TSMC is one of several chipmakers, including Intel and Wolfspeed, seeking to draw on government funding to build factories in Europe.

India, Vietnam hold 5th Joint Trade Sub-Commission meeting, explore bilateral trade expansion

Aug 8, 2023

India and Vietnam discussed the challenges in logistics that affect bilateral trade and agreed to explore direct shipping services, collaboration in freight movement and improving air connectivity, according to a release by Ministry of Commerce and Industry.

Florida Gov. Ron DeSantis faces crucial test in Trump's absence at Republican Debate

Aug 8, 2023

The Republican debate is a pivotal moment for Governor Ron DeSantis as he competes for the party's nomination against Donald Trump, who plans to skip the debate. DeSantis could face attacks from rivals aiming to position themselves as Trump's alternative, raising questions about his 2024 campaign readiness and spending.

US Congressmen Ro Khanna, Michael Waltz to lead delegation to India for PM Modi's Independence Day speech

Aug 8, 2023

US Congressmen Ro Khanna and Michael Waltz, co-chairs of the House India Caucus, will lead a bipartisan delegation to India, attending Prime Minister Narendra Modi's Independence Day address and engaging in discussions to strengthen US-India ties.